受强制性开放获取政策约束的文章 - SABAHATTİN SAİP了解详情
可在其他位置公开访问的文章：5 篇
Infliximab is a plausible alternative for neurologic complications of Behçet disease
B Zeydan, U Uygunoglu, S Saip, ON Demirci, E Seyahi, S Ugurlu, ...
Neurology: Neuroimmunology & Neuroinflammation 3 (5), e258, 2016
强制性开放获取政策： US National Institutes of Health
Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation
E Everest, M Ahangari, U Uygunoglu, M Tutuncu, A Bulbul, S Saip, ...
Scientific Reports 12 (1), 16984, 2022
强制性开放获取政策： US National Institutes of Health, Scientific and Technological Research …
Disease Characteristics of Seropositive Neuromyelitis Optica Spectrum Disorder in a Turkish Cohort
S Cam, B Gulec, M Tutuncu, S Saip, A Siva, U Uygunoglu
Neurology 99 (23_Supplement_2), S5-S5, 2022
强制性开放获取政策： Scientific and Technological Research Council of Turkey
POS1255 SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET’S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER
A Ozdede, S Güner, G Ozcifci, B Yurttas, ZT Dincer, Z Atli, U Uygunoglu, ...
Annals of the Rheumatic Diseases 81 (Suppl 1), 962-963, 2022
强制性开放获取政策： Netherlands Organisation for Health Research and Development
Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data
E Everest, E Ülgen, U Uygunoglu, M Tutuncu, S Saip, OU Sezerman, ...
PeerJ 9, e11922, 2021
强制性开放获取政策： Scientific and Technological Research Council of Turkey
出版信息和资助信息由计算机程序自动确定